Excelsior Biopharma Free Cash Flow Generation Index
Excelsior Biopharma free cash flow generation index. Excelsior Biopharma (6496) has a Free Cash Flow Generation Index of -2.80x as of June 2025. Free cash flow of NT$-10.64 Million represents -3% of operating cash flow (NT$3.80 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Excelsior Biopharma (2017–2022)
Free cash flow generation index of Excelsior Biopharma from 2017 to 2022. Historical FCF Generation Index trend for Excelsior Biopharma across 5 annual periods. See 6496 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Excelsior Biopharma Free Cash Flow Generation Index by Year (2017–2022)
Excelsior Biopharma free cash flow generation index by year from 2017 to 2022. Year-by-year Free Cash Flow Generation Index for Excelsior Biopharma. For the full cash flow conversion analysis, see Excelsior Biopharma operating cash flow efficiency.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | -0.42x | NT$-2.30 Million | NT$5.49 Million | NT$7.78 Million | ▼ -144.1% |
| 2021 | 0.95x | NT$52.95 Million | NT$55.82 Million | NT$2.88 Million | ▼ -3.0% |
| 2020 | 0.98x | NT$509.20 Million | NT$520.81 Million | NT$11.62 Million | ▲ +5.7% |
| 2018 | 0.92x | NT$117.38 Million | NT$126.92 Million | NT$9.54 Million | ▼ -2.4% |
| 2017 | 0.95x | NT$331.23 Million | NT$349.47 Million | NT$18.10 Million | — |